Today is World Contraception Day- and we recognise the millions of people around the world who still await greater choice and access to contraception. We’ve summarised 4 takeaways from the latest contraceptive R&D data in our ‘Is this the new era?’ report: www.impactglobalhealth.org/insights/rep...

🤔 Want a clear picture of the R&D landscape for endometriosis, PCOS and uterine fibroids? Explore our new infographics from our Flying Blind report: tinyurl.com/IGHflyingblind 🔍Endometriosis tinyurl.com/4whhbct7 🔍PCOS tinyurl.com/4wudeve4 🔍Uterine Fibroids tinyurl.com/2mjmmn6u

🚨Millions live with endometriosis, PCOS or uterine fibroids, yet LMIC-applicable R&D funding for all three combined was only $50m in 2023. Our new report, Flying Blind, shows how underinvestment keeps innovation stalled for women around the world: tinyurl.com/IGHflyingblind

⚠️ Antimicrobial resistance is rising fast and some STIs are at risk of becoming untreatable. Our new report, Irresistible, maps the funding, the pipeline, and the urgent need for action ➡️ tinyurl.com/IGHirresistible

🦟 This World Mosquito Day, we delve into our analysis of the 2025 Neglected Disease R&D Pipeline to understand where we stand in our fight against two vector-borne diseases: malaria and dengue 👉 shorturl.at/3tkrr Scroll below to see what the next generation of innovations for dengue may bring.

The Gates Foundation has announced funding to catalyze R&D for women's health around the world: shorturl.at/GzROg This is welcome news: our latest report, Is this the new era?, finds that female-only conditions remain a significant area of neglect: shorturl.at/krtw4

We developed the 100 Days Mission Scorecard in partnership with @ippsecretariat.org to assess our collective readiness to respond to pandemics. Five years on from the COVID-19 pandemic, the Scorecard reveals one stark reality: critical gaps remain 👇

👉🏾 Published today! The first in-depth analysis of Australia's public funding for global health research 2017-2023. Commissioned by the Australian Global Health Alliance, this report shows Australia could have a much greater role in addressing global health challenges. Take a look: bit.ly/3U1C5Ss

📢 Happening today! Let's Talk MPTs Webinar: Unlocking the Potential of MPTs Join us at 8:00 PT / 11:00 ET / 15:00 GMT / 17:00 SAST to discuss MPT funding trends with IMPT for Reproductive Health and FHI 360 Register here 🔗 bit.ly/3ZUOPgW

📢 Press release: The antimalarial toolbox just expanded, bringing hope to the smallest patients. The first #malaria treatment for newborns and young infants has been approved by @swissmedic.bsky.social, with fast-track approvals expected across Africa.

🧐 Curious about multipurpose prevention technologies (MPTs) that prevent HIV, STIs and/or pregnancy? Join us on Wednesday, 9 July 2025 at 8:00 PT / 11:00 ET / 15:00 GMT / 17:00 SAST to discuss MPT funding trends with IMPT for Reproductive Health and FHI 360 🔗 bit.ly/3ZUOPgW

#VaccinesWork. They are a huge success story - saving lives and helping economies grow. As the Gavi summit meets in Brussels today, let's pledge to go forwards. In April, our CEO @nickchapman.bsky.social outlined the risk of going backwards: www.impactglobalhealth.org/news/the-val...

Missed our launch? You can now watch the event here: www.youtube.com/watch?v=YoKs... Together with Dr Nigina Muntean from @unfpa.org, our team reveals and reflects on the critical trends, gaps, and opportunities to shape the future of SRH and women's health innovation.

🚨 DYK: in 2023, 40% of the world’s funding for SRH R&D focussed on LMIC populations came from the US government Join us tomorrow to explore how we can build resilience for this work in the face of sudden policy shifts and financing cuts 📅 June 17 ⏰ 1pm GMT 🔗 Register to join: shorturl.at/23vBR

Are you attending #EDCTPForum2025 in Kigali? Don’t miss our side meeting exploring how Africa-led networks, sustainable funding, and data can drive a new era of clinical research on the continent. 19 June 2025 | 13:30 – 15:00 | Kigali Convention Centre @drlindsaykeir.bsky.social

Why does Africa, home to 25% of the global disease burden, host less than 5% of the world’s clinical trials? Attending the EDCTP Forum 2025 in Kigali? Join @drlindsaykeir.bsky.social to explore:

💷 Yesterday, the UK Chancellor announced the results of the government's Spending Review Defence research funding will go up by 41% whilst ODA R&D will be halved, dropping from £800m to £400 by 2027 ⬇️ Yet, we know the extraordinary value of global health R&D for jobs & growth: shorturl.at/HxoMZ

🚀 Just one week to go until our launch event for Is This the New Era? Join us for a 45-minute interactive briefing on the state of sexual and reproductive health (SRH) and women’s health R&D funding. 🔗 shorturl.at/23vBR Don’t miss this chance to dive into the data, trends, and actionable takeaways.

📢 Join us for the launch of Is this the new era?, our latest report that examines the state of global funding for LMIC-applicable biomedical R&D targeting a range of sexual & reproductive health and women’s health issues. 📅 June 17 ⏰ 1pm GMT 🔗 Register to join: shorturl.at/23vBR

Visceral leishmaniasis claims thousands of lives each year, with children under 15 representing half of all cases. In this blog post, Vanessa Candeias celebrates the MOU signed by 6 African nations at #WHA78 to eliminate this deadly disease. www.impactglobalhealth.org/news/global-... @dndi.org

📢 The 18th annual G-FINDER survey is now open! Take part here: shorturl.at/TjEAj The G-FINDER survey tracks R&D funding for health issues impacting low- and middle-income countries. New to the G-FINDER? Email us at [email protected] to participate.

❤️‍🩹Global health R&D delivers global security and economic resilience. Our review of the neglected diseases R&D pipeline shows how close we are, and also how far away, from this situation. Read the report for more detail on how we can close the gap: www.impactglobalhealth.org/insights/rep...

What's in our R&D pipeline? We've been tracking products for neglected diseases since 2015 and now, for the first time, we’ve analysed the health of the pipeline. 🏁Which candidates are close to the finish line 💡What do breakthrough technologies offer www.impactglobalhealth.org/insights/rep...

We must enter a new era of appropriate R&D funding for women's health. 💡Our new analysis out now reviews the state of global funding and reveals we still have a long way to go to develop new clinical products that meet women's needs. ➡️Read the report: www.impactglobalhealth.org/insights/rep...

On #WorldMalariaDay we release new impact analysis of the UK's investment in neglected disease R&D. We highlight the extraordinary returns and warn we must not lose this progress as governments around the world announce significant cuts. ➡️ See the impact: www.impactglobalhealth.org/insights/rep...

💉 Vaccines save lives and must reach the people who need them most. ✂️Cuts to vaccine R&D funding are devastating. Just look at malaria: if 1 vaccine had launched faster, 2 million lives could’ve been saved. 🧠 Read Dr Nick Chapman’s call to action: 👉 bit.ly/4jB23Xq @malarianomore.org @gavi.org

🌎 Today is World Chagas Disease Day, an often overlooked disease that kills ~10,000 per year 💵 Our G-FINDER data shows a boost in Chagas drug R&D funding by industry in 2023 and US NIH funding rose by 25%, even as overall funding for multi-kinetoplastid R&D declined More info 👉 shorturl.at/up6l2

📢 Job alert! It's a new year for the G-FINDER survey and we're looking for several Research Assistants to join us for this important project. To read the job description and apply, visit www.impactglobalhealth.org/news/were-hiring-g-finder-casual-research-assistants

🌍 Yesterday was World Health Day and the launch of Healthy Beginnings, Hopeful Futures, a campaign focused on maternal & newborn health. Next month, we’ll release our new Sexual & Reproductive Health G-FINDER report, analysing R&D investments for 15 conditions, including 4 pregnancy-related ones

The EU has driven billions in economic benefits and job creation from neglected disease R&D. We call for sustained progress at the IAVI partner meeting: ✅ Push & pull investment mechanisms ✅ Funding across the R&D cycle ✅ Stronger coordination 🔗 www.impactglobalhealth.org/insights/hub...

📅 Today is the final day of Endometriosis Awareness Month & we've been moved by the stories shared by those affected. We're analysing R&D funding & product pipelines for an array of conditions that affect women. Make sure you're signed up to our newsletter to get all our insights: eepurl.com/i0EnRo

This #WorldTBDay, we recognise the urgency of ending tuberculosis- the world’s deadliest infectious disease. Our G-FINDER data shows the US NIH has consistently provided the most funding for TB R&D since 2009 bit.ly/4iVLGEC Yes! We Can End TB- and we need sustained & diversified funding to do so

PATH's new policy lab highlights the need to advance women's health (WH) innovations & how advocacy can drive change: bit.ly/4iEjVjM We fully agree & know that data can power this progress. If you haven't already, 👉 See R&D flows for WH 💰bit.ly/4htj44t 👉 Sign up for updates eepurl.com/i0EnRo

📄 Our latest policy briefing, developed in partnership with @path.org, provides key data, insights, and policy recommendations to strengthen Africa’s mpox diagnostic capacity and build resilient and strong African health systems. 👀 Read the briefing here: www.impactglobalhealth.org/insights/rep...

Interesting discussions at the @ceps.eu lab ideas on how to incentivize #PRNDs R&D in the EU. @impactglobalhealth.bsky.social's new report uncovers how EU investments in global health R&I deliver outstanding economic and societal benefits globally 🌍 Full report👉 bit.ly/EUReportFull #CEPSlab2025

🌐 The latest implementation report for the 100 Days Mission report offers a comprehensive assessment of how ready the world is to respond to another pandemic. Explore the report's key findings, scorecard, and priority actions for 2025: bit.ly/100DM-4thReport With @drlindsaykeir.bsky.social

US funding for global health is under threat, with staggering impacts. We urgently need a new, sustainable investment model. Our CEO, @nickchapman.bsky.social, shares Impact Global Health's commitment to global collaboration and co-creating solutions for a sustainable future: tinyurl.com/4hkza9ta

📰 We were delighted to partner with @dsw-intl.bsky.social to reveal our new report demonstrating that €1 invested in neglected disease R&D by the European Union and its Member States ultimately creates €5.67 in additional output. Read below for the full breakdown of returns 👇

‪Last month, @ippsecretariat.org published the latest #100DaysMission Scorecard, developed in collaboration with Impact Global Health. It shows that significant gaps remain across viral families- these must be addressed by policymakers, funders and developers: bit.ly/100DM-4thReport

🚀 Join us in advancing global health! We’re looking for experienced global health professionals to join our Global Advisory Council. Your support will help us navigate global trends and accelerate impact worldwide. Interested? Apply now: bit.ly/410ajtC 📌 This is an unpaid advisory role

💉What will give the EU economy a €12.8bn boost by 2040? 👉🏾Investing in R&D for global health. Today at the @sciencebusiness.net conference, we explore how health innovation strengthens the EU. Our report - a strong investment case for Europe - is online now ➡️ bit.ly/3WIpFk1 @dsw-de.bsky.social

🚀 Join us in advancing global health! We’re looking for experienced global health professionals to join our Global Advisory Council. Your support will help us navigate global trends and accelerate impact worldwide. Interested? Apply now: bit.ly/410ajtC 📌 This is an unpaid advisory role

🔥HOT TOPIC ALERT! 🔥 Q: Can you create a stronger, more competitive nation AND save the lives of millions of people worldwide? A: Yes - by investing in global health. The returns are extraordinary. Tune in on 6 February to hear how. Online registration is free of charge. Go! ⬇️ lnkd.in/e4gRUVTb

The latest #100DaysMission Scorecard, developed in collaboration with @ippsecretariat.org, shows that significant gaps remain across viral families. This needs to be addressed by policymakers, funders & developers for us to be ready to respond within 100 days of a pandemic threat: bit.ly/4hbRKZ8

This 🌏#WorldNTDDay let's celebrate the progress made in the fight against neglected diseases - and the smart decisions that drive change. Our latest G-FINDER report, just launched, helps you get to grips with the data and insights which empower smart decisions. Read it here ➡️➡️ bit.ly/3Eq8a1n

🥳Released today! Smart Decisions: The 2024 G-FINDER Neglected Disease R&D report Funding: flatlined. Tropical diseases: increasing with a hotter planet. Political shifts: changing the outlook for global health. Get to grips with what’s ahead. Read our latest report now ➡️ bit.ly/3Eq8a1n

What the world needs now....is smart decisions. Join us for the launch of the 2024 G-FINDER Neglected Disease R&D report to get to grips with the funding landscape and priorities being set for global health R&D investment. 30 January 2025. 08:00 EST / 13:00 GMT / 14:00 CET bit.ly/4ggBKEQ

What a packed audience for @ankomahalexankomah.bsky.social's poster presentation at the Conference on Neglected Tropical Diseases Research (InCORNTD) in Africa! There's still a few more hours to read our poster at MH3 in the NTD Research to Policy group or chat to Alex about our work. Get in touch 📨

🎤 We're attending the Conference on Neglected Tropical Diseases Research (InCORNTD) in Africa in Kigali, Rwanda 🌍 @ankomahalexankomah.bsky.social will be presenting 'Investing to End the Neglect for Skin-Related NTDs: Insights from the G-Finder Project' on Jan 22. #GAELF2025 #GlobalHealth #NTDs

The R&D landscape for neglected diseases shows choices are being made. But are they the right ones? Join us for an online webinar as we launch the latest G-FINDER report on neglected diseases R&D. ➡️Register now ➡️bit.ly/4ggBKEQ